Viewing Study NCT00620295


Ignite Creation Date: 2025-12-24 @ 2:04 PM
Ignite Modification Date: 2026-02-20 @ 1:25 AM
Study NCT ID: NCT00620295
Status: COMPLETED
Last Update Posted: 2017-11-29
First Post: 2008-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Colorectal Cancer View
None Head and Neck Cancer View
None Kidney Cancer View
None Lung Cancer View
None Ovarian Cancer View
None Pancreatic Cancer View
None Prostate Cancer View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent pancreatic cancer View
None recurrent breast cancer View
None recurrent small cell lung cancer View
None recurrent non-small cell lung cancer View
None recurrent colon cancer View
None recurrent prostate cancer View
None recurrent head and neck cancer View
None ovarian cancer View
None recurrent uterine cancer View
None recurrent kidney cancer View
None recurrent osteosarcoma View